Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Characteristics of Toxicity Occurring in Outpatients at Korean Medical Clinics in Korean

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2016, v.37 no.1, pp.135-150



  • Downloaded
  • Viewed

Abstract

Research Methods: This research analyzed the data on those aged 20 and older from the Report on Korean Medicine Usage Research, which was conducted in 2011. The definitions of toxicity were defined by the presence of toxicity listed in the survey. The questions used in analysis were sex, age, household income, health insurance, medical fees, satisfaction rates on treatments, as well as the types of diseases and the presence of toxicity from treatments. The analysis was done through frequency analysis using SAS 9.2 and Fisher’s Exact Test. Results: Toxicity occurred in 2.1% patients out of the 3518 studied. The types of toxicity were skin problems, such as hives and pruritus (34.7%), gastrointestinal problems (20.8%), neurological diseases (4.2%), liver(1.4%), kidney toxicity(1.4%), and others (22.2%). There were no differences in toxicity by sex, age, household income and the types of health insurances. However, toxicity were positively correlated with the increase in standard of education (p=0.0124). In addition, as treatment costs increased (p<0.0001) and satisfaction rates decreased, toxicity increased (p<0.0001). Toxicity increased in patients with low back pain (p=0.0429), hwabyung (p=0.0392), lumbar sprain (p=0.0004), correction body type (p=0.0118), growth (p=0.0045), and from motor accidents (p=0.0448). In logistic regression analysis, Toxicity were positively correlated with medical fees, and cancer treatment and negatively correlated with satisfaction rate on treatments. Conclusion: The toxicity that occurred in outpatients who used Korean medical clinics mostly happened in skin, digestive organs, nerves, livers, and kidneys toxicity. The occurrences differed by the Educational lengths, expensive costs of treatments, low satisfaction rates of the treatments, and cancer.

keywords
Characteristics Toxicity, Korean Medicine Clinics, Outpatients


Reference

1

1. Wikipedia. Side effect. 2014. Available at:URL:https://en.wikipedia. org/wiki/Side_effect.

2

2. U.S. Department Of Health and Human Services, Traditional Chinese Medicine: An Introduction. 2010

3

3. World Health Organization. New WHO guidelines to promete proper use of alternative medicines. 2004.

4

4. Ko SG, Jang BE, Choi JS. ADR of Herbal Medicines. Korean Journal of Oriental Physiology &Pathology. 2004;18(4):957-964.

5

5. Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJD, Herbal bioactivation : The good, the bad and the ugly. Life Science. 2004;74:935-968.

6

6. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicine. Trends in pharmacological sciences. 2002;23(3):136-139.

7

7. Bensoussan A, Myers SP, Drew AK, Whyte IM, Dawson AH. Development of a Chinese herbal medicine toxicology database. Journal of Toxicology and Clinical Toxicology. 2002;40(2):159-167.

8

8. Greensfelder L. Alternative medicine. Herbal product linked to cancer. Science. 2000;288:1946.

9

9. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. NEJM. 2000;343:1833-1838.

10

10. Kessler DA. Cancer and herbs. NEJM. 2000;342:1742-1743.

11

11. McRae CA, Agarwal K, Mutimer D, Bassendine MF. Hepatitis associated with Chinese herbs. European Journal of Gastroenterology and Hepatology. 2002;14:669-562.

12

12. Stedman C. Herbal hepatotoxicity. Seminars in Liver Disease. 2002;22(2):195-206.

13

13. Villegas JF, Barabe DN, Stein RA, Lazar E. Adverse effects of herbal treatment of cardiovascular disease: what the physician must know. Heart Disease. 2001;3(3):169-175.

14

14. Zaacks SM, Klein L, Tan CD, Rodriguez ER, Leikin JB. Hypersensitivity myocarditis associated with ephedra use. J of Toxico and Clin Toxicol. 1999;37(4):485-489.

15

15. Woo YJ, Chung SY, Park BJ. Current Status of Spontaneous Adverse Reactions Reporting System on Herbal Medicine in China, Japan, Korea and WHO. J. Int. Korean Med. 2014:35(2)111-118.

16

16. Ministry of Health and Welfares. Usage and Consumption of Korean Medicine. 2011.

17

17. Park TS, Lee SY. An introduction to categorical data analysis. Freeaca. 1999.

18

18. Yoo TW, Kim BI, Kim JB, Kim DJ, Kim JW, Baik SK, et al. The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean; A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury.The Korean Journal of Hepatology. 2007;13(1):34-43.

19

19. Seo JC, Jeon WJ, Park SS, Kim SH, Lee KM, Chae HB, et al. Clinical experience of 48 acute toxic hepatitis patients. The Korean Journal of Hepatology 2006;12(1):74-81.

20

20. Jang JS, Seo EG, Han C, Chae HB, Kim SJ, Lee JD, et al. Four cases of toxic liver injury associated with dictamnus dasycarpus. The Korean Journal of Hepatology. 2008;14(1):206-212.

21

21. Ministry of Health and Welfares. Usage and Consumption of Korean Medicine. 2014.

22

22. Korean Institute for Health and Social Affairs. Usage and Consumption of Korean Medicine and Perception in Korea. 2012.

23

23. Rolf T, Axel E. Herbal hepatotoxicity in traditional and modern medicine: actual key issue and new encouraging steps. Frontiers in Pharmacology. 2015;6:72.

24

24. Li Z, Jingbo Y, Xinmin L, Zuguang Y, Xiaohui Y. Ronald Meyboom, Kelvin Chan, Debbie Shaw, Pierre Duez, Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective. Journal of Ethnopharmacology. 2012;140:519-525.

25

25. Choi HJ. The side effects of using herbal medicine with western medicine. Jornal of Korean society of hospital pharmacists. 2003;20(2):1-9.

26

26. Kim YH, Kim JH. The Benefits of the National Health Insurance and Oriental Medical Services. The Journal of Oriental Medical Preventive. 2007;11(1):139-151.

27

27. Kim NJ. Expand and development insurance coverage of Korean traditional medicine. Korea Institute of Oriental Medicine. 1996.

28

28. Shin YD. Research on the present coverage of health insurance of Korean traditional medicine and its activation Plan. Kyung Hee University. 2000.

29

29. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, et al. Specialized Committee for Drung-Induced Liver Disease Chinese Pharmacological Society. Comparison between Chinese herbal medicine and western medicine-induced liver injury of 1985 patients. Journal of Gastroenterology and Hepatology. 2016.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine